Eledon Pharmaceuticals, Inc. (ELDN)
3.20
-0.12
(-3.61%)
USD |
NASDAQ |
Aug 28, 16:00
3.21
+0.01
(+0.31%)
After-Hours: 20:00
Eledon Pharmaceuticals Total Return Price : 3.20 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 28, 2026 | 3.20 |
| August 27, 2026 | 3.32 |
| August 26, 2026 | 3.35 |
| August 25, 2026 | 3.47 |
| August 24, 2026 | 3.41 |
| August 21, 2026 | 3.45 |
| August 20, 2026 | 3.52 |
| August 19, 2026 | 3.55 |
| August 18, 2026 | 3.62 |
| August 17, 2026 | 3.58 |
| August 14, 2026 | 3.54 |
| August 13, 2026 | 3.70 |
| August 12, 2026 | 3.77 |
| August 11, 2026 | 3.75 |
| August 10, 2026 | 3.68 |
| August 07, 2026 | 3.69 |
| August 06, 2026 | 3.46 |
| August 05, 2026 | 3.44 |
| August 04, 2026 | 3.49 |
| August 03, 2026 | 3.43 |
| July 31, 2026 | 3.38 |
| July 30, 2026 | 3.41 |
| July 29, 2026 | 3.31 |
| July 28, 2026 | 3.40 |
| July 27, 2026 | 3.57 |
| Date | Value |
|---|---|
| July 24, 2026 | 3.58 |
| July 23, 2026 | 3.74 |
| July 22, 2026 | 3.72 |
| July 21, 2026 | 3.95 |
| July 20, 2026 | 3.86 |
| July 17, 2026 | 4.07 |
| July 16, 2026 | 3.84 |
| July 15, 2026 | 4.02 |
| July 14, 2026 | 4.05 |
| July 13, 2026 | 3.86 |
| July 10, 2026 | 3.85 |
| July 09, 2026 | 4.13 |
| July 08, 2026 | 4.21 |
| July 07, 2026 | 3.93 |
| July 06, 2026 | 3.97 |
| July 02, 2026 | 3.95 |
| July 01, 2026 | 3.90 |
| June 30, 2026 | 3.94 |
| June 29, 2026 | 3.88 |
| June 26, 2026 | 3.78 |
| June 25, 2026 | 3.65 |
| June 24, 2026 | 3.96 |
| June 23, 2026 | 3.95 |
| June 22, 2026 | 3.81 |
| June 18, 2026 | 3.92 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 541.69 |
| Viking Therapeutics, Inc. | 32.16 |
| ACADIA Pharmaceuticals, Inc. | 29.11 |
| Alnylam Pharmaceuticals, Inc. | 237.10 |
| Anika Therapeutics, Inc. | 21.10 |